DK486088A - Hmg-coa reduktaseinhibitor og fremgangsmaade til fremstilling deraf - Google Patents

Hmg-coa reduktaseinhibitor og fremgangsmaade til fremstilling deraf

Info

Publication number
DK486088A
DK486088A DK486088A DK486088A DK486088A DK 486088 A DK486088 A DK 486088A DK 486088 A DK486088 A DK 486088A DK 486088 A DK486088 A DK 486088A DK 486088 A DK486088 A DK 486088A
Authority
DK
Denmark
Prior art keywords
hmg
preparing
procedure
coa reductase
reductase inhibitor
Prior art date
Application number
DK486088A
Other languages
English (en)
Other versions
DK486088D0 (da
Inventor
Ta Jyh Lee
Robert L Smith
Gerald E Stokker
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of DK486088D0 publication Critical patent/DK486088D0/da
Publication of DK486088A publication Critical patent/DK486088A/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/16Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D309/28Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/30Oxygen atoms, e.g. delta-lactones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK486088A 1987-09-02 1988-09-01 Hmg-coa reduktaseinhibitor og fremgangsmaade til fremstilling deraf DK486088A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US9235387A 1987-09-02 1987-09-02

Publications (2)

Publication Number Publication Date
DK486088D0 DK486088D0 (da) 1988-09-01
DK486088A true DK486088A (da) 1989-03-03

Family

ID=22232821

Family Applications (1)

Application Number Title Priority Date Filing Date
DK486088A DK486088A (da) 1987-09-02 1988-09-01 Hmg-coa reduktaseinhibitor og fremgangsmaade til fremstilling deraf

Country Status (5)

Country Link
EP (1) EP0306263B1 (da)
JP (1) JPH0196151A (da)
CA (1) CA1307263C (da)
DE (1) DE3869282D1 (da)
DK (1) DK486088A (da)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5001148A (en) * 1989-06-07 1991-03-19 E. R. Squibb & Sons, Inc. Mevinic acid derivatives
DE69008277D1 (de) * 1989-08-31 1994-05-26 Merck & Co Inc 7-Subsituierte HMG-CoA-Reduktase-Inhibitoren.
CN114558618B (zh) * 2022-01-04 2023-10-31 山东理工大学 一类叠氮-炔环加成多酸基光催化剂的制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK149080C (da) * 1980-06-06 1986-07-28 Sankyo Co Fremgangsmaade til fremstilling af derivater af ml-236b-carboxylsyre
US4376863A (en) * 1981-08-21 1983-03-15 Merck & Co., Inc. Hypocholesterolemic fermentation products
JPS5835144A (ja) * 1981-08-27 1983-03-01 Sankyo Co Ltd Mb−530b誘導体およびその製造法
JPS5889191A (ja) * 1981-11-20 1983-05-27 Sankyo Co Ltd 3−ヒドロキシ−ml−236b誘導体の製造法
JPS59122483A (ja) * 1982-12-28 1984-07-14 Nippon Chemiphar Co Ltd 新規なモナコリン誘導体
US4611068A (en) * 1984-11-19 1986-09-09 Merck Frosst Canada, Inc. Process for the preparation of HMG-CoA reductase inhibitors and intermediate compounds employed therein
PT85109A (en) * 1986-06-23 1987-07-01 Merck & Co Inc Process for the preparation of hydroxy-tetrahydropyranone derivatives or corresponding ring opened dihydroxy acids which are hmg-coa reductase inhibitors

Also Published As

Publication number Publication date
EP0306263A2 (en) 1989-03-08
JPH0196151A (ja) 1989-04-14
EP0306263B1 (en) 1992-03-18
EP0306263A3 (en) 1989-08-23
DK486088D0 (da) 1988-09-01
CA1307263C (en) 1992-09-08
DE3869282D1 (de) 1992-04-23

Similar Documents

Publication Publication Date Title
DK370486D0 (da) Hmg-coa-reduktaseinhibitor og fremgangsmaade til fremstilling deraf
JPS6426535A (en) Novel hmg-coa reductase inhibitor
PH25350A (en) PHOSPHOROUS-CONTAINING HMG-CoA REDUCTASE INHIBITORS
EP0251625A3 (en) Novel hmg-coa reductase inhibitors
DK226888A (da) Steroid 5-alfa-reduktase inhibitor
EP0403487A4 (en) Novel hmg-coa reductase inhibitors
DK277388D0 (da) Phosphorholdige hmg-coa-reduktase-inhibitorer, mellemprodukter og fremgangsmaade
DK134288A (da) Kemo-radio-immuno-konjugat og fremgangsmaade til fremstilling heraf
DK485888D0 (da) Hmg-coa reduktaseinhibitor og fremgangsmaade til fremstilling deraf
EP0323866A3 (en) Novel hmg-coa reductase inhibitors
DK306189D0 (da) Immobiliseret lipasepraeparat og anvendelse deraf til estersyntese
DK486088A (da) Hmg-coa reduktaseinhibitor og fremgangsmaade til fremstilling deraf
DE69008277D1 (de) 7-Subsituierte HMG-CoA-Reduktase-Inhibitoren.
DK251087D0 (da) Dopamin-beta-hydrolaseinhibitorer og fremgangsmaade til fremstilling deraf
DK422989D0 (da) Quinolin- og pyridinankre for hmg-coa-reductaseinhibitorer
NO860092L (no) Korrosjons-inhibitor og fremgangsmaate til fremstilling derav.
EP0320052A3 (en) Intermediates and processes for 6-carboxy hmg-coa reductase inhibitors
DK25388D0 (da) Kondenserede pyrazolderivater og fremgangsmaade til fremstilling heraf
ZA874487B (en) Novel hmg-coa reductase inhibitors
IE871654L (en) Novel hmg-coa reductase inhibitors
IE861739L (en) Hmg-coa reductase inhibitors
IE882652L (en) NOVEL HMG-CoA REDUCTASE INHIBITORS
ZA894895B (en) 5-oxygenated hmg-coa reductase inhibitors
IE822652L (en) HMG-CoA REDUCTASE INHIBITORS
DK577688D0 (da) Fastgoerelsessorgan og fremgangsmaade til fremstilling heraf

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment